AngioDynamics/$ANGO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About AngioDynamics

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Ticker

$ANGO
Primary listing

Industry

Health Care Equipment & Supplies

Employees

748

ISIN

US03475V1017

AngioDynamics Metrics

BasicAdvanced
$415M
-
-$1.02
0.52
-

What the Analysts think about AngioDynamics

Analyst ratings (Buy, Hold, Sell) for AngioDynamics stock.

Bulls say / Bears say

AngioDynamics reported a third-quarter fiscal 2025 adjusted EPS of $0.03, surpassing the consensus estimate of a $0.13 loss, indicating improved financial performance. (benzinga.com)
The company's Med Tech segment achieved a 22.2% increase in net sales, driven by strong growth across all product lines, including a 161.4% rise in AlphaVac sales, showcasing robust demand for its innovative products. (benzinga.com)
AngioDynamics received European CE Mark approval for its AlphaVac F1885 System, expanding its market reach and potential revenue streams in the European market. (businesswire.com)
AngioDynamics revised its fiscal 2024 net sales guidance downward to $270 million-$275 million from the earlier outlook of $320 million-$325 million, reflecting challenges in meeting previous revenue expectations. (finance.yahoo.com)
The company reported a 4.2% decline in revenue to $72 million for the quarter ended February 28, 2025, compared to the same period a year ago, indicating potential difficulties in sustaining growth. (tradingview.com)
AngioDynamics announced a restructuring plan involving facility closures and employee terminations, with estimated costs ranging from $38.5 million to $43.25 million, which may impact short-term profitability. (tradingview.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.

AngioDynamics Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

AngioDynamics Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ANGO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs